Literature DB >> 17401524

A population based study of respiratory function in motor neuron disease patients living in Tayside and North East Fife, Scotland.

Shuna Colville1, Robert J Swingler, Ian S Grant, Fiona L R Williams.   

Abstract

Respiratory failure is a major cause of morbidity and the principal cause of death in motor neuron disease; non-invasive ventilation is increasingly used worldwide to palliate the respiratory symptoms. This observational study was designed to evaluate the prevalence of respiratory insufficiency within the motor neuron disease population of Tayside and North East Fife, Scotland. Twenty-six patients were identified, their diagnosis confirmed according to agreed criteria and subjected to the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale, the Epworth Sleepiness questionnaire; spirometry, sniff nasal inspiratory pressure and nocturnal pulse oximetry measurements.Twenty-two (84.6%) patients reported one or more symptoms of respiratory insufficiency, 19 patients (73%) had forced vital capacity <80% of predicted in the sitting position and 10 (38.5%) had oxygen saturation <90% for >5% of night. On this basis a potential 10 patients required consideration for ventilation. As well as probable improvement in quality of life and survival for those patients this potential increase in workload has major educational, management and resource implications for health care providers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401524     DOI: 10.1007/s00415-006-0389-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Treating respiratory failure in ALS: the details are becoming clearer.

Authors:  Edward Anthony Oppenheimer
Journal:  J Neurol Sci       Date:  2003-05-15       Impact factor: 3.181

Review 2.  The management of motor neurone disease.

Authors:  P N Leigh; S Abrahams; A Al-Chalabi; M-A Ampong; L H Goldstein; J Johnson; R Lyall; J Moxham; N Mustfa; A Rio; C Shaw; E Willey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

3.  Vital capacity as an efficacy measure: pro.

Authors:  Robert J Fallat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2002

4.  Non-invasive ventilation in motor neuron disease: current UK practice.

Authors:  S C Bourke; T L Williams; R E Bullock; G J Gibson; P J Shaw
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2002-09

5.  El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.

Authors:  B R Brooks
Journal:  J Neurol Sci       Date:  1994-07       Impact factor: 3.181

6.  A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients.

Authors:  C E Jackson; J Rosenfeld; D H Moore; W W Bryan; R J Barohn; M Wrench; D Myers; L Heberlin; R King; J Smith; D Gelinas; R G Miller
Journal:  J Neurol Sci       Date:  2001-10-15       Impact factor: 3.181

7.  Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis.

Authors:  Ross K Morgan; Stephen McNally; Michael Alexander; Ronan Conroy; Orla Hardiman; Richard W Costello
Journal:  Am J Respir Crit Care Med       Date:  2004-10-29       Impact factor: 21.405

8.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

9.  Noninvasive ventilation in ALS: indications and effect on quality of life.

Authors:  S C Bourke; R E Bullock; T L Williams; P J Shaw; G J Gibson
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

10.  Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers.

Authors:  Dagmar Kaub-Wittemer; Nicole von Steinbüchel; Maria Wasner; Gerhard Laier-Groeneveld; Gian Domenico Borasio
Journal:  J Pain Symptom Manage       Date:  2003-10       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.